![Martin Lange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Lange
Director Técnico/Científico/I+D en
NOVO NORDISK A/S
.
Perfil
Martin Holst Lange is Director at Pharmacosmos A since 2023.
Dr. Lange is Chief Scientific Officer & Executive VP at Novo Nordisk A since 2002.
Formerly, Dr. Lange was Medical Director at Novo Nordisk, Inc. from 2006 to 2008.
Dr. Lange was Director at Beta Bionics, Inc. from 2017 to 2020.
Education includes two doctorates from the University of Copenhagen, conferred in 1997 and 2004.
Cargos activos de Martin Lange
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVO NORDISK A/S | Director Técnico/Científico/I+D | 07/08/2025 |
Pharmacosmos A/S
 Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Director/Miembro de la Junta | 18/08/2023 |
Antiguos cargos conocidos de Martin Lange.
| Empresas | Cargo | Fin |
|---|---|---|
| BETA BIONICS, INC. | Director/Miembro de la Junta | 20/02/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Director Técnico/Científico/I+D | 01/01/2008 |
Formación de Martin Lange.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
77
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
- Bolsa de valores
- Insiders
- Martin Lange
